Sponsor:
Aaron Cook
Code:
NCT07643467
Conditions
Augmented Renal Clearance
Critical Illness
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Relmapirazin
Iohexol
Medibeacon tGFR monitor
Urine creatinine clearance collection
Brief summary:
Conditions
Augmented Renal Clearance
Critical Illness
Study ID
NCT07643467
Start date
Sep 1, 2026
Status verified date
Oct, 2026
Completion date
Jun 30, 2028
Anticipated
Primary completion date
May 31, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Enrollment
200 participants
Anticipated
Intervention Model
Single group
Primary purpose
Diagnostic
Arms
experimental: MediBeacon Transdermal Glomerular Filtration Rate (GFR) Monitoring
Interventions
Relmapirazin
Iohexol
Medibeacon tGFR monitor
Urine creatinine clearance collection
Primary outcome measure
Central contacts
Locations
UKHealthCare/University of Kentucky
Recruiting
Lexington, Kentucky, United States, 40536
Sponsor
Aaron Cook
Last update posted
Oct 7, 2026
Last verified
Oct, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-08. This information was provided to ClinicalTrials.gov by Aaron Cook on 2026-10-07. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.